Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021

SELL
$5.35 - $6.35 $847,846 - $1.01 Million
-158,476 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$5.68 - $7.87 $900,143 - $1.25 Million
158,476 New
158,476 $952,000
Q3 2019

Oct 22, 2019

SELL
$4.86 - $6.05 $1.56 Million - $1.94 Million
-320,723 Closed
0 $0
Q2 2019

Aug 15, 2019

SELL
$4.51 - $6.6 $733,979 - $1.07 Million
-162,745 Reduced 33.66%
320,723 $1.8 Million
Q1 2019

May 15, 2019

SELL
$5.16 - $6.85 $115,372 - $153,159
-22,359 Reduced 4.42%
483,468 $3.01 Million
Q4 2018

Feb 06, 2019

BUY
$4.89 - $7.16 $92,200 - $135,001
18,855 Added 3.87%
505,827 $2.57 Million
Q3 2018

Oct 16, 2018

BUY
$6.89 - $7.78 $111,445 - $125,841
16,175 Added 3.44%
486,972 $3.51 Million
Q2 2018

Jul 17, 2018

BUY
$5.19 - $7.25 $295 - $413
57 Added 0.01%
470,797 $3.14 Million
Q1 2018

Apr 26, 2018

BUY
$3.56 - $5.74 $1.68 Million - $2.7 Million
470,740 New
470,740 $2.58 Million

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $273M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.